Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · technology

Biopharmaceutical company breaks ground in Hamilton

9 October 2026 · By · Wire by Fusion42

Published

9 October 2026

Topic

technology

◆ Sectors

Biotech

◆ Geography

United States

◆ Source

Read at nbcmontana.com →

◆ Verified

Fusion42 · 9 October 2026 · Fusion42 review

Tonix, a New Jersey-based biopharmaceutical company, has broken ground on a phased manufacturing facility in Hamilton, Montana to produce an antibody aimed at preventing Lyme disease.

This Wire brief sits within Fusion42's coverage of Biotech.

◆ ◆ The Wire takeaway

Tonix's new manufacturing site opens a fresh production base for Lyme disease antibodies, signalling opportunity for suppliers and regional biotech ventures to tap into emerging local pharma capabilities.

◆ Coverage

1 source · 9 Oct 2026

◆ Related on Wire

◆ Topics

Biotechbiopharmaceuticalfacility-expansionlyme-diseasemanufacturingmontanatonix